Client : DIRECT

Patient Name : Mr. S KRISHNA

Age/Gender : 45 years / Male Sample Type : Plas - F
Phone : 9618518430 Registered On : 09 Mar 2019 08:53 AM
Ref. Dr. : SELF Collected On : 09 Mar 2019 08:54 AM
Req. No : 031903144201 Reported On : 09 Mar 2019 02:20 PM

Clinical Biochemistry
Glucose, Fasting (FBS)
Test Name Observed Values Units Biological Reference Intervals

Fasting Plasma Glucose 78.0 mg/dL Normal : 70 - 100

(Method : Hexokinase) Impaired GT: 101 - 125
Diabetic : > /=126

Reference:
American Diabetes association guidelines 2016.
Remarks:
Postprandial hypoglycemia may be observed in persons taking certain diabetes medications, antibiotics and alcoholic
beverages. Additionally intestinal disorders, endocrine disorders, insulin surge, nature of diet, reduced food intake than usual
and stress are among several other factors.
Please correlate clinically.

**END OF REPORT**
Client : DIRECT
Patient Name : Mr. S KRISHNA
Age/Gender : 45 years / Male Sample Type : WHOLE BLOOD
Phone : 9618518430 Registered On : 09 Mar 2019 08:53 AM
Ref. Dr. : SELF Collected On : 09 Mar 2019 08:54 AM
Req. No : 031903144200 Reported On : 09 Mar 2019 01:30 PM

Clinical Biochemistry
Glycosylated Hb (HbA1C)
Test Name Observed Values Units Biological Reference Intervals

Glycosylated Hb (HbA1C) 5.5 % Non-diabetic level: 4.0- 6.0

(Method : High-performance Iiquid chromatography) Goal: 6.1 - 7.
Good control: 7.1 - 8.0
Action suggested: >8.0

Estimated Average Glucose 111.1 mg/dL -

Reference:
Tosoh G8 Variant Manual.

**END OF REPORT**
Client : DIRECT
Patient Name : Mr. S KRISHNA
Age/Gender : 45 years / Male Sample Type : WHOLE BLOOD
Phone : 9618518430 Registered On : 09 Mar 2019 08:53 AM
Ref. Dr. : SELF Collected On : 09 Mar 2019 08:54 AM
Req. No : 031903144200 Reported On : 09 Mar 2019 01:05 PM

Hematology
Complete Blood Picture (CBP)
Test Name Observed Values Units Biological Reference Intervals

Hemoglobin 13.5 g/dL 13.0 - 17.0

(Method : Colorimetry)

PCV/HCT 40.5 % 40.0 - 50.0

(Method : Calculated)

Total RBC Count 4.87 mill/cumm 4.50 - 5.50

(Method : Electrical Impedance)

Total WBC Count 5300 cells/cumm 4000 – 10000

(Method : Electrical Impedance)

Platelet Count 2.74 lakhs/cumm 1.50 – 4.10

(Method : Electrical Impedance)

DIFFERENTIAL COUNT
Neutrophils 47.9 % 40 – 80
Lymphocytes 42.8 % 20-40
Eosinophils 1.7 % 1–6
Monocytes 7.2 % 2 - 10
Basophils 0.4 % 0-2
(Method : VCS / Microscopy)

PERIPHERAL BLOOD PICTURE

RBC Normocytic ,Normochromic
WBC Relative lymphocytosis
Platelets Adequate

Method : Microscopy,Fully Automated Hematology Analyser

 
Reference :
Dacie and Lewis Practical Hematology,10th Edition
Note : These results are generated by a fully automated hematology analyzer and the differential count is
computed from a total of several thousands of cells. Therefore the differential count appears in decimalised
numbers and may not add upto exactly 100. It may fall between 99 and 101.

**END OF REPORT**
Client : DIRECT
Patient Name : Mr. S KRISHNA
Age/Gender : 45 years / Male Sample Type : WHOLE BLOOD
Phone : 9618518430 Registered On : 09 Mar 2019 08:53 AM
Ref. Dr. : SELF Collected On : 09 Mar 2019 08:54 AM
Req. No : 031903144200 Reported On : 09 Mar 2019 01:18 PM

Hematology
Erythrocyte Sedimentation Rate (ESR)
Test Name Observed Values Units Biological Reference Intervals

E.S.R 1st HOUR 08 mm/hour Male: 0 – 10 mm/1st hr

(Method : Westergren/ Vesmatic) Female: 0 – 15 mm/1st hr

Reference:

User Manual of Vesmatic 20/20 Plus New

Interpretation:

Erythrocyte sedimentation rate (ESR) is a useful but nonspecific marker of underlying inflammation.
ESR is elevated in: Rheumatoid arthritis, chronic infection, collagen disease, polyclonal hyperglobulinemia and
hyperfibrinogenemia Temporal arteritis, septic arthritis, pelvic inflammatory disease, and appendicitis, Osteomyelitis.
Neoplastic disease- Myeloma or Macroglobulinemia, Prostate cancer, Hodgkin’s disease, Renal cell carcinoma. Stroke,
coronary artery disease Pregnancy - increase at the 10th to the 12th week, and returns to normal about 1 month postpartum.
ESR is decreased in:
polycythemia, hyperviscosity, sickle cell anemia, leukemia, low plasma protein (liver, kidney disease) and congestive heart
failure.

Reference: Henry’s Clinical Diagnosis and Management by Laboratory Methods, 22nd edition, page-521.

**END OF REPORT**
Client : DIRECT
Patient Name : Mr. S KRISHNA
Age/Gender : 45 years / Male Sample Type : Serum
Phone : 9618518430 Registered On : 09 Mar 2019 08:53 AM
Ref. Dr. : SELF Collected On : 09 Mar 2019 08:54 AM
Req. No : 031903144200 Reported On : 09 Mar 2019 03:45 PM

Clinical Biochemistry
Lipid Profile
Test Name Observed Values Units Biological Reference Intervals

Total Cholesterol 170.0 mg/dL Desirable : Upto 200

(Method : CHO-POD) Borderline: 200 - 239
High : >/= 240

HDL Cholesterol 41.0 mg/dL Major risk factor for heart disease:
(Method : Enzymatic Immunoinhibition) < 40
Negative risk factor for heart
disease: > 60

LDL Cholesterol 84.4 mg/dL Optimal : < 100

(Method : Calculated) Near optimal: 100 - 129
Borderline : 130 - 159
High 160 - 189
Very High : >1= 190

VLDL Cholesterol 44.6 mg/dL 6.0 - 38.0

(Method : Calculated)

Triglycerides 223.0 mg/dL Normal : < 150

(Method : GPO-POD) Borderline : 150 - 199
High : 200 - 499
Very High : >/= 500

CHOL / HDL Ratio 4.1 3.5 - 5.0

(Method : Calculated)

Reference :
The National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) report.

**END OF REPORT**
Client : DIRECT
Patient Name : Mr. S KRISHNA
Age/Gender : 45 years / Male Sample Type : Serum
Phone : 9618518430 Registered On : 09 Mar 2019 08:53 AM
Ref. Dr. : SELF Collected On : 09 Mar 2019 08:54 AM
Req. No : 031903144200 Reported On : 09 Mar 2019 05:05 PM

Clinical Biochemistry
Liver Function Test (LFT)
Test Name Observed Values Units Biological Reference Intervals

Total Bilirubin 0.4 mg/dL 0.3 - 1.2

(Method : DPD)

Direct Bilirubin 0.1 mg/dL < 0.2

(Method : DPD)

Indirect Bilirubin 0.3 mg/dL 0.0 - 0.8

(Method : Calculated)

ALT (SGPT) 39.0 IU/L < 50

(Method : IFCC (without Pyridoxal Phosphate
Activation))

AST (SGOT) 33.0 IU/L < 50

(Method : IFCC (without pyridoxal Phosphate
Activation))

Alkaline Phosphtase 73.0 IU/L 30 - 120

(Method : IFCC AMP-Buffer)

Total Protein 7.5 g/dL 6.6 - 8.3

(Method : Biuret)

Albumin 4.8 g/dL 3.4 - 5.0

(Method : Bromocresol Green (BCG))

Globulin 2.7 g/dL 1.8 - 3.8

(Method : Calculated)

A/G Ratio. 1.8 0.9 - 1.8

(Method : Calculated)

References:
Beckman kit literature and Tietz fundamentals of clinical chemistry

**END OF REPORT**
Client : DIRECT
Patient Name : Mr. S KRISHNA
Age/Gender : 45 years / Male Sample Type : Serum
Phone : 9618518430 Registered On : 09 Mar 2019 08:53 AM
Ref. Dr. : SELF Collected On : 09 Mar 2019 08:54 AM
Req. No : 031903144200 Reported On : 09 Mar 2019 03:45 PM

Clinical Biochemistry
Creatinine, Serum
Test Name Observed Values Units Biological Reference Intervals

Creatinine,Serum 0.7 mg/dL 0.67-1.17

(Method : Modified Jaffe, Kinetic)

Reference :
Beckman kit literature & Tietz fundamentals of clinical chemistry (Children)

**END OF REPORT**
Client : DIRECT
Patient Name : Mr. S KRISHNA
Age/Gender : 45 years / Male Sample Type : Serum
Phone : 9618518430 Registered On : 09 Mar 2019 08:53 AM
Ref. Dr. : SELF Collected On : 09 Mar 2019 08:54 AM
Req. No : 031903144200 Reported On : 09 Mar 2019 04:33 PM

Clinical Biochemistry
Blood Urea Nitrogen (BUN)
Test Name Observed Values Units Biological Reference Intervals

Blood Urea Nitrogen 13.1 mg/dL 7 - 18

(Method : Calculated)

Reference
In blood, Urea is usually reported as BUN and expressed in mg/dl. BUN mass units can be converted to urea mass units by
multiplying by 2.14. Beckman kit literature.

**END OF REPORT**
Client : DIRECT
Patient Name : Mr. S KRISHNA
Age/Gender : 45 years / Male Sample Type : Serum
Phone : 9618518430 Registered On : 09 Mar 2019 08:53 AM
Ref. Dr. : SELF Collected On : 09 Mar 2019 08:54 AM
Req. No : 031903144200 Reported On : 09 Mar 2019 05:11 PM

Clinical Biochemistry
Electrolytes, Serum
Test Name Observed Values Units Biological Reference Intervals

Sodium, Serum 140.0 mmol/L 136 - 146

Potassium,Serum 4.5 mmol/L 3.5 - 5.1

Chloride,Serum 103.0 mmol/L 101 - 109

Method
ISE Indirect

Reference:
Beckman kit literature.

**END OF REPORT**
Client : DIRECT
Patient Name : Mr. S KRISHNA
Age/Gender : 45 years / Male Sample Type : Serum
Phone : 9618518430 Registered On : 09 Mar 2019 08:53 AM
Ref. Dr. : SELF Collected On : 09 Mar 2019 08:54 AM
Req. No : 031903144200 Reported On : 09 Mar 2019 05:05 PM

Clinical Biochemistry
Uric Acid, Serum
Test Name Observed Values Units Biological Reference Intervals

Uric Acid 5.6 mg/dL 3.5 - 7.2

(Method : Uricase PAP)

Reference:
Beckman kit literature

**END OF REPORT**
Client : DIRECT
Patient Name : Mr. S KRISHNA
Age/Gender : 45 years / Male Sample Type : Serum
Phone : 9618518430 Registered On : 09 Mar 2019 08:53 AM
Ref. Dr. : SELF Collected On : 09 Mar 2019 08:54 AM
Req. No : 031903144200 Reported On : 09 Mar 2019 05:05 PM

Clinical Biochemistry
Calcium, Serum
Test Name Observed Values Units Biological Reference Intervals

Calcium, Serum 9.6 mg/dL 8.8 – 10.6

(Method : Arsenazo III )

Reference:
Beckman kit literature

Note: Kindly correlate clinically.

**END OF REPORT**
Client : DIRECT
Patient Name : Mr. S KRISHNA
Age/Gender : 45 years / Male Sample Type : Serum
Phone : 9618518430 Registered On : 09 Mar 2019 08:53 AM
Ref. Dr. : SELF Collected On : 09 Mar 2019 08:54 AM
Req. No : 031903144200 Reported On : 09 Mar 2019 04:59 PM

Clinical Biochemistry
Transferrin Saturation
Test Name Observed Values Units Biological Reference Intervals

Transferrin Saturation 22.0 % 20 - 50

(Method : Calculated)

**END OF REPORT**
Client : DIRECT
Patient Name : Mr. S KRISHNA
Age/Gender : 45 years / Male Sample Type : Serum
Phone : 9618518430 Registered On : 09 Mar 2019 08:53 AM
Ref. Dr. : SELF Collected On : 09 Mar 2019 08:54 AM
Req. No : 031903144200 Reported On : 09 Mar 2019 04:59 PM

Clinical Biochemistry
Iron with TIBC
Test Name Observed Values Units Biological Reference Intervals

Iron 75.0 µg/dL 70 - 180

(Method : TPTZ)

TIBC 341.0 µg/dL 155 - 355

(Method : Nitroso-PSAP)
Referece
Beckman kit literature

**END OF REPORT**
Client : DIRECT
Patient Name : Mr. S KRISHNA
Age/Gender : 45 years / Male Sample Type : Serum
Phone : 9618518430 Registered On : 09 Mar 2019 08:53 AM
Ref. Dr. : SELF Collected On : 09 Mar 2019 08:54 AM
Req. No : 031903144200 Reported On : 09 Mar 2019 03:31 PM

Clinical Biochemistry
Thyroid Profile (T3,T4,TSH)
Test Name Observed Values Units Biological Reference Intervals

Total Tri iodothyronine (T3) 0.56 ng/mL 0.75 - 1.78

(Method : CLIA)

Total Thyroxine (T4) 4.84 µg/dL 6.09 - 12.23

(Method : CLIA)

Thyroid Stimulating Hormone (TSH) 3.20 µIU/mL 0.38 - 5.33

(Method : CLIA)

Note: Kindly correlate clinically.

Interpretation :

1. T3 and T4 values may be altered due to changes in serum proteins Pregnancy drugs, Nephrosis etc. In such cases, Free
T3 and Free T4 give corrected value.
2. TSH values may be transiently altered in severe infections, liver disease, renal and heart failure, severe burns, trauma, and
surgery etc.
3. Drugs that decrease TSH values - L-dopa, Glucocorticoids. Drugs that increase TSH values -Iodine, Lithium, Amiodarone.

Reference: Beckman caliper study of pediatric, Beckman manufacture& Tietz fundamentals of clinical chemistry 6TH edition

**END OF REPORT**
Client : DIRECT
Patient Name : Mr. S KRISHNA
Age/Gender : 45 years / Male Sample Type : Serum
Phone : 9618518430 Registered On : 09 Mar 2019 08:53 AM
Ref. Dr. : SELF Collected On : 09 Mar 2019 08:54 AM
Req. No : 031903144200 Reported On : 09 Mar 2019 03:05 PM

Immunology
Rheumatoid Factor (RA Factor)
Test Name Observed Values Units Biological Reference Intervals

RA Factor <10.0 IU/ml </=14

(Method : Immunoturbidimetry)

Interpretation:
Rheumatoid factor levels elevated in 70-90% of patients with Rheumatoid arthritis.

Rheumatoid factor may be elevated in other rheumatic and non-rheumatic diseases such as Hepatitis ,Endocarditis and in
autoimmune diseases.

**END OF REPORT**
Client : DIRECT
Patient Name : Mr. S KRISHNA
Age/Gender : 45 years / Male Sample Type : Serum
Phone : 9618518430 Registered On : 09 Mar 2019 08:53 AM
Ref. Dr. : SELF Collected On : 09 Mar 2019 08:54 AM
Req. No : 031903144200 Reported On : 09 Mar 2019 03:46 PM

Clinical Biochemistry
Vitamin B12 (Cyanocobalamine),Serum
Test Name Observed Values Units Biological Reference Intervals

Vitamin B12,Serum 244 pg/ml 180-914

(Method : CLIA)

Reference:
Beckman kit literature.

Interpretation :
1. Vit B12 levels are decreased in megaloblastic anemia, partial/total gastrectomy, pernicious anemia, peripheral
neuropathies, chronic alcoholism, senile dementia, and treated epilepsy.
2. An associated increase in homocysteine levels is an independent risk marker for cardiovascular disease and deep vein
thrombosis .
3. HoloTranscobalamin II levels are a more accurate marker of active Vit B12 component.

**END OF REPORT**
Client : DIRECT
Patient Name : Mr. S KRISHNA
Age/Gender : 45 years / Male Sample Type : Serum
Phone : 9618518430 Registered On : 09 Mar 2019 08:53 AM
Ref. Dr. : SELF Collected On : 09 Mar 2019 08:54 AM
Req. No : 031903144200 Reported On : 09 Mar 2019 05:00 PM

Clinical Biochemistry
25 Hydroxy Vitamin D
Test Name Observed Values Units Biological Reference Intervals

25 Hydroxy (OH) Vitamin D 30.17 ng/mL Deficiency : Below 20

(Method : CLIA) Insufficiency: 20 - 30
Sufficiency : 30 - 100
Toxicity : Above 100

Reference:
Beckman kit literature■

Interpretation :
Vitamin D is a fat soluble vitamin and exists in two main forms as cholecalciferol(vitamin D3) which is synthesized in skin from
7-dehydrocholesterol in response to sunlight exposure & Ergocalciferol(vitamin D2) present mainly in dietary sources.Both
cholecalciferol & Ergocalciferol are converted to 25(OH)vitamin D in liver. Testing for 25(OH)vitamin D is recommended as it is
the best indicator of vitamin D nutritional status as obtained from sunlight exposure & dietary intake. For diagnosis of vitamin D
deficiency it is recommended to have clinical correlation with serum 25(OH)vitamin D, serum calcium, serum PTH & serum
alkaline phosphatase. During monitoring of oral vitamin D therapy- suggested testing of serum 25(OH)vitamin D is after 12
weeks or 3 mths of treatment. However, the required dosage of vitamin D supplements & time to achieve sufficient vitamin D
levels show significant seasonal(especially winter) & individual variability depending on age, body fat, sun exposure, physical
activity ,genetic factors(especially variable vitamin D receptor responses), associated liver or renal disease, malabsorption
syndromes and calcium or magnesium deficiency influencing the vitamin D metabolism Vitamin D toxicity is known but very
rare.kindly correlate clinically, repeat with fresh sample if indicated.

**END OF REPORT**